CD146: friend or foe of the lung?

By Ana Espino | Published on August 18, 2025 | 2 min read
  
#CD146 #Immunology #RespiratoryDisease #Immunotherapy  


Respiratory diseases are among the leading causes of morbidity and mortality worldwide, affecting millions of people every year and creating a substantial socio-economic burden. They encompass a wide range of pathologies of inflammatory, tumoral, or infectious origin, often with severe and rapidly evolving courses. Current therapeutic approaches remain limited, partly because they insufficiently address vascular mechanisms and angiogenesis, which play key roles in pulmonary pathophysiology.